RU2007123141A - MEANS FOR STIMULATING THE CHOICE OF BLOOD ROOF CELLS IN BLOOD - Google Patents
MEANS FOR STIMULATING THE CHOICE OF BLOOD ROOF CELLS IN BLOOD Download PDFInfo
- Publication number
- RU2007123141A RU2007123141A RU2007123141/15A RU2007123141A RU2007123141A RU 2007123141 A RU2007123141 A RU 2007123141A RU 2007123141/15 A RU2007123141/15 A RU 2007123141/15A RU 2007123141 A RU2007123141 A RU 2007123141A RU 2007123141 A RU2007123141 A RU 2007123141A
- Authority
- RU
- Russia
- Prior art keywords
- stimulating
- release
- blood
- polyisoprenoid
- bloodstream
- Prior art date
Links
- 230000004936 stimulating effect Effects 0.000 title claims abstract 15
- 239000008280 blood Substances 0.000 title abstract 5
- 210000004369 blood Anatomy 0.000 title abstract 5
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims abstract 13
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 claims abstract 4
- 229910019142 PO4 Inorganic materials 0.000 claims abstract 4
- GYBNOAFGEKAZTA-QOLULZROSA-N [(6z,10e,14e)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OCCC(C)CC\C=C(\C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C GYBNOAFGEKAZTA-QOLULZROSA-N 0.000 claims abstract 4
- 239000003795 chemical substances by application Substances 0.000 claims abstract 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract 4
- 239000010452 phosphate Substances 0.000 claims abstract 4
- 229920001550 polyprenyl Polymers 0.000 claims abstract 4
- 125000001185 polyprenyl group Polymers 0.000 claims abstract 4
- 210000000601 blood cell Anatomy 0.000 claims 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1. Средство для стимуляции выброса стволовых кроветворных клеток в кровоток, содержащее хотя бы один полиизопреноид.2. Средство для стимуляции выброса стволовых кроветворных клеток в кровоток по п.1, отличающееся тем, что хотя бы один полиизопреноид является фосфорилированным.3. Средство для стимуляции выброса стволовых кроветворных клеток в кровоток по п.2, отличающееся тем, что в качестве фосфорилированного полиизопреноида использован полипренилфосфат.4. Средство для стимуляции выброса стволовых кроветворных клеток в кровоток по п.2, отличающееся тем, что в качестве фосфорилированного полиизопреноида использован долихилфосфат.5. Средство для стимуляции выброса стволовых кроветворных клеток в кровоток по п.3, отличающееся тем, что использован полипренилфосфат с N изопреновыми звеньями, N=[7,22].6. Средство для стимуляции выброса стволовых кроветворных клеток в кровоток по п.4, отличающееся тем, что использован долихилфосфат с N изопреновыми звеньями, N=[7,22].7. Средство для стимуляции выброса стволовых кроветворных клеток в кровоток по любому из пп.1-6, отличающееся тем, что использованы полиизопреноиды природного происхождения.1. An agent for stimulating the release of hematopoietic stem cells into the bloodstream containing at least one polyisoprenoid. 2. An agent for stimulating the release of hematopoietic stem cells into the blood stream according to claim 1, characterized in that at least one polyisoprenoid is phosphorylated. A means for stimulating the release of hematopoietic stem cells into the blood stream according to claim 2, characterized in that polyprenyl phosphate is used as the phosphorylated polyisoprenoid. 4. A means for stimulating the release of hematopoietic stem cells into the blood stream according to claim 2, characterized in that dolichyl phosphate is used as the phosphorylated polyisoprenoid. The agent for stimulating the release of hematopoietic stem cells into the bloodstream according to claim 3, characterized in that polyprenyl phosphate with N isoprene units is used, N = [7.22] .6. A means for stimulating the release of hematopoietic stem cells into the bloodstream according to claim 4, characterized in that dolichylphosphate with N isoprene units is used, N = [7.22]. 7. A tool for stimulating the release of stem hematopoietic cells into the bloodstream according to any one of claims 1 to 6, characterized in that polyisoprenoids of natural origin are used.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2007123141/15A RU2392929C2 (en) | 2007-06-20 | 2007-06-20 | Agent stimulating hemopoietic stem cell emission in blood flow |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2007123141/15A RU2392929C2 (en) | 2007-06-20 | 2007-06-20 | Agent stimulating hemopoietic stem cell emission in blood flow |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2007123141A true RU2007123141A (en) | 2008-12-27 |
| RU2392929C2 RU2392929C2 (en) | 2010-06-27 |
Family
ID=42683863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007123141/15A RU2392929C2 (en) | 2007-06-20 | 2007-06-20 | Agent stimulating hemopoietic stem cell emission in blood flow |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2392929C2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011129716A1 (en) * | 2010-04-13 | 2011-10-20 | Общество С Ограниченной Ответственностью "Гaмabeтфapм" | Means for the prophylaxis and treatment of acute and chronic pancreatitis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2005475C1 (en) * | 1991-10-01 | 1994-01-15 | Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи | Antiviral agent |
| US5731357A (en) * | 1996-01-18 | 1998-03-24 | Rubens; Juris | Immunomodulating active substance |
| RU2177788C2 (en) * | 1998-06-10 | 2002-01-10 | Данилов Леонид Леонидович | Preparation to prevent and treat infectious diseases and correct pathological states |
| DE19830732B4 (en) * | 1998-07-09 | 2008-11-13 | Lts Lohmann Therapie-Systeme Ag | Composition containing at least one substance influencing blood lipid levels and its use |
| RU2189231C1 (en) * | 2001-01-12 | 2002-09-20 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Emulsion preparation for prophylaxis of respiratory viral infections |
| BRPI0412581A (en) * | 2003-07-31 | 2006-09-19 | Pharmacia & Upjohn Co Llc | dispersible formulation of an anti-inflammatory agent |
-
2007
- 2007-06-20 RU RU2007123141/15A patent/RU2392929C2/en active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011129716A1 (en) * | 2010-04-13 | 2011-10-20 | Общество С Ограниченной Ответственностью "Гaмabeтфapм" | Means for the prophylaxis and treatment of acute and chronic pancreatitis |
| EA020344B1 (en) * | 2010-04-13 | 2014-10-30 | Общество С Ограниченной Ответственностью "Гамаветфарм" | Means for the prophylaxis and treatment of acute and chronic pancreatitis |
Also Published As
| Publication number | Publication date |
|---|---|
| RU2392929C2 (en) | 2010-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013006073A (en) | Blood collection devices containing blood stabilization agent. | |
| MX339769B (en) | Systems, methods and compositions for optimizing tissue and cell enriched grafts. | |
| MX339624B (en) | IMPROVED COMPOSITIONS OF CELLS AND METHODS TO PREPARE THE SAME. | |
| NO20074856L (en) | Transcarotenoid, their synthesis, formulation and use | |
| WO2007121443A3 (en) | Differentiation of multi-lineage progenitor cells to respiratory epithelial cells | |
| WO2017163132A3 (en) | Use of umbilical cord blood derived exosomes for tissue repair | |
| BR112014009837A8 (en) | effective use of yeast and yeast extract | |
| BR112013002081A2 (en) | sacroiliac stabilization system | |
| WO2011091420A3 (en) | Osteogenic cell delivery matrix | |
| BR112015022444A2 (en) | wound dressing dressing and use | |
| AR077199A1 (en) | PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE FOR EMERGENCY ANTI-CONCEPTION | |
| BR112015006426A2 (en) | nutritional compositions including beta-hydroxy-beta-methylbutyrate, protein and low electrolyte levels | |
| WO2009100280A3 (en) | 3-dimensional silk hydroxyapatite compositions | |
| EP4241856A3 (en) | Tube for the preparation of wound healant composition | |
| TW200700092A (en) | Tigecycline compositions and methods of preparation | |
| BR112012027179A2 (en) | microbial growth resistant oral hygiene compositions | |
| EA201100153A1 (en) | NICOTON-CONTAINING SOFT GELATINUM PASTILES | |
| EP2314274A3 (en) | Compositions comprising a superhydrophilic amphiphilic copolymer and a micellar thickener | |
| MX2009009756A (en) | Devices and methods for acid and base generation. | |
| BR112014031220A2 (en) | breathable electrode structure and method and system for use in water separation | |
| BR112014003139A2 (en) | leach-resistant wetting peat moss, method of preparation, and method of use | |
| WO2011034916A3 (en) | Bone substitute compositions, methods of preparation and clinical applications | |
| WO2014186508A8 (en) | Human extensively self-renewing erythroblasts (esre) | |
| AR067140A2 (en) | NEW PROCESS FOR TREATMENT OF FRUITS OR VEGETABLES THROUGH THE PHOSPHORUS ION AND THE CORRESPONDING COMPOSITIONS | |
| WO2010100570A3 (en) | Activated leukocyte composition |